ALECSAT
ALECSAT (Autologous Lymphoid Effector Cells Specific Against Tumor cells) technology is a novel method of epigenetic cancer immunotherapy being used by the company . It uses a patient's own immune system to target tumor cells in prostate cancer, glioblastomas, and potentially pancreatic cancer. ALECSAT research, directed by Alexei Kirken and Karine Dzhandzhugazyan, has led to several clinical trials.
primaryTopic
ALECSAT
ALECSAT (Autologous Lymphoid Effector Cells Specific Against Tumor cells) technology is a novel method of epigenetic cancer immunotherapy being used by the company . It uses a patient's own immune system to target tumor cells in prostate cancer, glioblastomas, and potentially pancreatic cancer. ALECSAT research, directed by Alexei Kirken and Karine Dzhandzhugazyan, has led to several clinical trials.
has abstract
ALECSAT (Autologous Lymphoid E ...... ed to several clinical trials.
@en
Wikipage page ID
35,739,540
page length (characters) of wiki page
Wikipage revision ID
997,970,253
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
subject
hypernym
type
comment
ALECSAT (Autologous Lymphoid E ...... ed to several clinical trials.
@en
label
ALECSAT
@en